Drug Pipeline

Tenecteplase (TNK) (0.25 mg/kg, to maximum of 25mg) Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
1
Recruiting
2
Phase 3
2
Top Sponsors
Active Studies by Phase
Phase 3
2
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07253181 Tenecteplase Before Interhospital Transfer for EVT in Acute Anterior Circulation LVO at… Acute Ischemic Stroke Recruiting
NCT07475949 Unknown Time of Onset Stroke RePerfusIon Without Advanced Imaging Acute Ischemic Stroke Not Yet Recruiting
Not specified
NCT07475936 Intravenous Tenecteplase in Very Old Patients With Acute Ischemic Stroke Acute Ischemic Stroke Not Yet Recruiting
Sponsors Running Tenecteplase (TNK) (0.25 mg/kg, to maximum of 25mg) Trials
First Affiliated Hospital of Guangxi Medical University (2) Xuanwu Hospital, Beijing (1)
Disease Areas
Stroke (3)
Get alerts when Tenecteplase (TNK) (0.25 mg/kg, to maximum of 25mg) trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free